NEW YORK (Reuters) -Federal Reserve Bank of New York President John Williams said Wednesday that monetary policy is in the ...

More than two-thirds of Japanese firms believe the government should compile an extra budget later this year to mitigate the ...

A 17% tariff on tomatoes could end up costing the country far more than we gain, even if the deal moves more production ...

Gary Cohn, IBM vice chairman and former National Economic Council Director under President Trump, joins 'Squawk Box' to ...

America’s trading partners have largely failed to retaliate against Donald Trump’s sweeping tariffs, allowing a president ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

Investing.com - The second-quarter earnings season is likely to show the first material impact on Corporate America from an incremental rise in U.S. tariffs, according to analysts at Barclays. In a ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.

Johnson & Johnson (JNJ) has reportedly revised its forecast of the impact of U.S. President Donald Trump’s tariffs to $200 ...

Nevertheless, the underlying data was clearly more relevant to the market: some categories likely to be initially impacted by the tariffs recorded further sharp increases. This reinforced market ...

Raphael Bostic remains focused on economic data despite Trump's criticism of Powell, noting that businesses in the southeast are experiencing real price pressures from tariffs.

Positive impact on the financial market and economic growth is expected from the reduction in Trump's tariffs, according to Bank Indonesia governor.